Neurologic Disease

Neurologic Disease - most related articles:

- Pay more attention to epilepsy, affects millions of people - 3.1
- TENS device for pain not recommended for chronic low back pain - 3
- Smoking may increase multiple sclerosis risk - 2.1

Neurologic Disease articles

Bexarotene cancer drug may reverse Alzheimer's symptoms
Neuroscientists at Case Western Reserve University School of Medicine have made a dramatic breakthrough in their efforts to find a cure for Alzheimer's disease. The research shows that use of a drug in mice appears to quickly reverse the pathological, cognitive and memory deficits caused by the onset of Alzheimer's.

Understanding working of parkin gene and Parkinson's disease
Parkinson's disease researchers at the University at Buffalo have discovered how mutations in the parkin gene cause the disease, which afflicts at least 500,000 Americans and for which there is no cure. The results are published in the current issue of Nature Communications.

Brain stimulating habits lowers Alzheimer's disease risk
Individuals who keep their brains active throughout life with cognitively stimulating activities such as reading, writing and playing games appear to have reduced levels of the ß-amyloid protein, which is the major part of the amyloid plaque in Alzheimer disease.

29 new genetic variants linked to multiple sclerosis
Scientists have identified 29 new genetic variants linked to multiple sclerosis, providing key insights into the biology of a very debilitating neurological disease. Many of the genes implicated in the study are relevant to the immune system, shedding light onto the immunological pathways that underlie the development of multiple sclerosis.

Stem cells take cues from CSF fluid in brain
Proteins in fluids bathing the brain are essential for building the brain, revealed by researchers in the journal Neuron. The finding promises to advance research related to neurological disease, cancer and stem cells.

Gene therapy clearing toxic proteins in brain may prevent Alzheimer's disease
Gene therapy that boosts the ability of brain cells to gobble up toxic proteins prevents development of Alzheimer's disease in mice that are predestined to develop it, report researchers at Georgetown University Medical Center.

A new way to test blood for Alzheimer's disease
Using a new technology that relies on thousands of synthetic molecules to fish for disease-specific antibodies, researchers have developed a potential method for detecting Alzheimer's disease with a simple blood test.

Smoking may increase multiple sclerosis risk
Smoking may increase the risk of multiple sclerosis (MS) in people who also have specific established risk factors for MS. The research is found in the April_7, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Gene variation linked to lower risk of dementia, Alzheimer's disease
Preliminary research suggests that variation of a gene for a plasma protein is associated with slower age-related memory decline and a lower risk of dementia and Alzheimer disease (AD).

Testing gene therapy for Alzheimer's disease
University Hospitals Case Medical Center is one of 12 sites conducting the first Phase 2 clinical trial of a gene therapy for Alzheimer's disease (AD). The study uses a viral-based gene transfer system called CERE-110, which is designed to deliver nerve growth factor (NGF) into the brain.

Extra virgin olive oil prevents Alzheimer's disease
Natural compound, Oleocanthal, in extra virgin olive oil targets toxic beta amyloid proteins in patients with Alzheimer's disease, revealed by US researchers. Extra virgin olive oil contains the highest amount of polyphenol antioxidants also.

Gene therapy may cure Alzheimer's disease
To stop the progression of Alzheimer's disease, scientists are conducting gene therapy trial on patients with a mild form of Alzheimer's Disease in US.

Coffee may reverse Alzheimer's disease
Caffeine significantly decreased abnormal levels of the protein linked to Alzheimer's disease, both in the brains and in the blood of mice exhibiting symptoms of the disease, revealed by researchers.

Peptide Abeta a new marker for Alzheimer's disease
Researchers in Japan have detected a peptide in cerebrospinal fluid (CSF) that can show whether a person is developing Alzheimer's disease. Measuring the level of this peptide could show that the disease process has started, long before any serious damage is done to the brain.

Cognitive impairment linked to reduced survival in US
Alzheimer's disease and its precursor, mild cognitive impairment, appear to be associated with an increased risk of death among both white and African American older adults according to a new, long-term research study by neurological experts at the Alzheimer's Disease Center at Rush University Medical Center.

Alzheimer's Society comment on new tau tangle research
New research published in Nature Cell Biology suggests that tangle formation can be transferred from one type of trans genetic mouse line to another.

Alzheimer's Society comment on benefits of weekly curry
Professor Murali Doraiswamy, from the Duke University Medical Center in Carolina, has suggested that curcumin, found in the popular curry ingredient tumeric, could help prevent the onset of dementia.

Heart disorder linked to Alzheimer's disease dementia
Researchers at Intermountain Medical Center in Salt Lake City believe that they have made a breakthrough connection between atrial fibrillation, a fairly common heart rhythm disorder, and Alzheimer's disease, the leading form of dementia among Americans.

Alzheimer's disease risk index predicts Alzheimer's in elderly
A new tool can help predict whether people age 65 and older have a high risk of developing Alzheimer's disease. Research on the tool is published in the May 13, 2009, online issue of Neurology, the medical journal of the American Academy of Neurology.

Alzheimer's disease - most expensive disease, Maria Shriver
Sargent Shriver, an advisor to two presidents and the first director of the Peace Corps, no longer remembers the name of his daughter: Maria, California's first lady and former television reporter. He has Alzheimer's disease.

Pain relievers seem not to prevent Alzheimer's disease
A new study shows that nonsteroidal anti-inflammatory drugs (NSAIDs) such as the pain relievers ibuprofen and naproxen do not prevent Alzheimer's disease, but they may instead delay its onset.

SAP a new therapeutic target in Alzheimer's disease
New therapeutic approaches in Alzheimer's disease are urgently needed. Work led by Professor Mark Pepys FRS over more than 20 years has identified a protein known as serum amyloid P component (SAP) as a possible therapeutic target in Alzheimer's disease.

A-beta clearance - a key to treatment or prevention of Alzheimer's disease
In Alzheimer's disease the brain accumulates a molecule called A-beta that can be quite toxic to brain cells. Many researchers believe that finding ways to clear A-beta may be a key to treatment or prevention of Alzheimer's disease.

Passive smoking linked to dementia
Researchers from the Peninsula Medical School, the University of Cambridge and the University of Michigan have published the results of the first large-scale study to indicate that second-hand smoke exposure could lead to dementia and other neurological problems.

MRI shows brain atrophy pattern that predicts Alzheimer's Disease
Researchers have identified a pattern of regional brain atrophy in patients with mild cognitive impairment (MCI) that indicates a greater likelihood of progression to Alzheimer's disease. Researchers used special MRI methods.

Insulin may slow or prevent Alzheimer's disease
Insulin, by shielding memory-forming synapses from harm, may slow or prevent the damage and memory loss caused by toxic proteins in Alzheimer's disease, reported by researchers at Northwestern University.

NICE's decision on Alzheimer's drugs based on flawed calculations
Thousands of people with early stage Alzheimer's are being denied access to the only drugs for the disease due to fundamental flaws in the way their cost effectiveness has been calculated.

Genetic disease recreated in lab
When neurons started dying in Clive Svendsen's lab dishes, he couldn't have been more pleased. The dying cells – the same type lost in patients with the devastating neurological disease spinal muscular atrophy – confirmed that the University of Wisconsin-Madison stem cell biologist had recreated the hallmarks of a genetic disorder in the lab, using stem cells derived from a patient.

Yeast to identify drugs for Alzheimer's disease
CSIRO scientists have developed a new system to screen for compounds that can inhibit one of the processes that takes place during the progression of Alzheimer's disease.

New drug alemtuzumab for multiple sclerosis patients
A drug which was developed in Cambridge and initially designed to treat a form of leukaemia has also proven effective against combating the debilitating neurological disease multiple sclerosis (MS).

Fatty acids linked to Alzheimer's disease
Scientists at the Gladstone Institute of Neurological Disease (GIND) and the University of California have found that complete or partial removal of an enzyme that regulates fatty acid levels improves cognitive deficits in a mouse model of Alzheimer's disease (AD).

Vitamin B does not slow cognitive decline in Alzheimer's disease
A clinical trial led by Paul S. Aisen, M.D., professor of neurosciences at the University of California, San Diego School of Medicine, showed that high-dose vitamin B supplements did not slow the rate of cognitive decline in patients with mild to moderate Alzheimer disease.

32 Neurologic Disease articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
0.94